Cancer drugs could be grown in chicken eggs

| October 16, 2017
eggs
Today's delicious breakfast food could be the cancer drug factory of tomorrow
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Japanese researchers have genetically engineered hens whose eggs contain drugs that can fight serious diseases including cancer, in a bid to dramatically reduce the cost of treatment, a report said (October 9th, 2017).

Researchers at the National Institute of Advanced Industrial Science and Technology (AIST) in the Kansai region kicked off the process by introducing genes that produce interferon beta into cells which are precursors of chicken sperm, the newspaper reported.

They then used these cells to fertilise eggs and create hens which inherited those genes, meaning the birds were able to lay eggs containing the disease-fighting agent.

The scientists now have three hens whose eggs contain the drug, with the birds laying eggs almost daily, the report said.

The researchers plan to sell the drug to pharmaceutical companies, halving its price, so the firms can use it first as a research material, the newspaper said.

Consumers may have to wait a while, as Japan has strict regulations concerning the introduction of new or foreign pharmaceutical products, with screening processes that routinely take years to complete.

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion and analysis. Read full, original post: Japan scientists grow drugs in chicken eggs

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend